202 related articles for article (PubMed ID: 31849109)
21. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
22. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
[TBL] [Abstract][Full Text] [Related]
23. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
24. Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid.
Stallworth JY; Smith LD; Vagefi MR; Pekmezci M
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e104-e106. PubMed ID: 35797671
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis Type 1 with a Giant Diffuse Plexiform Neurofibroma Invading the Liver.
Yokogawa Y; Suzuki T; Suzuki H; Nemoto R; Shimizu H; Ueda T; Uchihara D; Okubo Y; Ichii O; Tai M; Ejiri Y; Harada M
Intern Med; 2023 Oct; 62(20):2971-2975. PubMed ID: 36792186
[TBL] [Abstract][Full Text] [Related]
26. A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy.
Vaassen P; Feldkamp A; Scholz M; Blau T; Dürr NR; Rosenbaum T
Childs Nerv Syst; 2023 Nov; 39(11):3301-3304. PubMed ID: 37344677
[TBL] [Abstract][Full Text] [Related]
27. Dramatic Improvement of a Massive Plexiform Neurofibroma After Administration of Selumetinib.
Passos J; Nzwalo H; Azevedo M; Tavares M; Nunes S
Pediatr Neurol; 2020 Apr; 105():69-70. PubMed ID: 31917098
[No Abstract] [Full Text] [Related]
28. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
Lin V; Daniel S; Forte V
Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
[TBL] [Abstract][Full Text] [Related]
29. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ; Shih CS; Rhodes SD; Armstrong AE; Wolters PL; Dombi E; Zhang C; Angus SP; Johnson GL; Packer RJ; Allen JC; Ullrich NJ; Goldman S; Gutmann DH; Plotkin SR; Rosser T; Robertson KA; Widemann BC; Smith AE; Bessler WK; He Y; Park SJ; Mund JA; Jiang L; Bijangi-Vishehsaraei K; Robinson CT; Cutter GR; Korf BR; ; Blakeley JO; Clapp DW
Nat Med; 2021 Jan; 27(1):165-173. PubMed ID: 33442015
[TBL] [Abstract][Full Text] [Related]
30. A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
Anderson MK; Johnson M; Thornburg L; Halford Z
Ann Pharmacother; 2022 Jun; 56(6):716-726. PubMed ID: 34541874
[TBL] [Abstract][Full Text] [Related]
31. Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA.
Yang X; Yoo HK; Amin S; Cheng WY; Sundaresan S; Zhang L; Duh MS
Childs Nerv Syst; 2022 Aug; 38(8):1513-1522. PubMed ID: 35579709
[TBL] [Abstract][Full Text] [Related]
32. French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study.
Wolkenstein P; Chaix Y; Entz Werle N; Amini-Adle M; Barbarot S; Boileau C; Miled A; Rashid T; Aerts I
Eur J Med Genet; 2023 May; 66(5):104734. PubMed ID: 36868501
[TBL] [Abstract][Full Text] [Related]
33. [Plexiform neurofibroma of the bladder associated with neurofibromatosis type 1: a case report].
Nakazawa S; Yoneda S; Takezawa K; Tanigawa G; Fujita K; Okumi M; Hosomi M; Fukuhara S; Fushimi H; Yamaguchi S
Hinyokika Kiyo; 2012 Apr; 58(4):215-8. PubMed ID: 22684263
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
[TBL] [Abstract][Full Text] [Related]
35. [Plexiform cervical neurofibroma: about a case].
Bouimetarhan L; Bellamlih H; En-Nafaa I; Fenni JE; Amil T; Radouane B
Pan Afr Med J; 2018; 30():41. PubMed ID: 30167068
[TBL] [Abstract][Full Text] [Related]
36. Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019.
Collins-Sawaragi YC; Ferner R; Vassallo G; De Agrò G; Eccles S; Cadwgan J; Hargrave D; Hupton E; Eelloo J; Lunt L; Tang V; Burkitt Wright E; Lascelles K
Am J Med Genet A; 2022 Jun; 188(6):1723-1727. PubMed ID: 35178860
[TBL] [Abstract][Full Text] [Related]
37. Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2017 Nov; 44(11):1262-1267. PubMed ID: 29098729
[TBL] [Abstract][Full Text] [Related]
38. MULTIPLE NEUROENDOCRINE NEOPLASIA IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (NF1): REPORT OF A NEW MUTATION (NF1, EXONS 2-30 DELETION) AND LITERATURE REVIEW.
Kanno DT; Mattos RLM; Campos FG; Siqueira RM; Carvalho RB; Real Martinez CA
Arq Bras Cir Dig; 2023; 35():e1702. PubMed ID: 36629684
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.
Schalkwijk S; Zhou L; Cohen-Rabbie S; Jain L; Freshwater T; So K; He Z; Gioni I; Tomkinson H; Vishwanathan K; Zhou D
Cancer Chemother Pharmacol; 2021 Aug; 88(2):189-202. PubMed ID: 33903938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
